semaglutide
(2)Company
Company
Health
Prolynx and the Longer Clock for Obesity Drugs
A tiny chemical timer could stretch a weekly injection into a monthly one. Prolynx has the mouse data, a $70 million financing, and a much harder question still to answer in people.
biotechnology · obesity-drugsRead →
Health · Consumer · Saas
Embla Wants Employers to Buy Less GLP-1 - and Better Weight Care
The Danish-founded health company built a weight-care business around an unfashionable proposition: the expensive drug should be a temporary tool, not the entire product. Its next test is whether a 2,694-person real-world study can persuade American benefits buyers.
digital-health · weight-managementRead →